TET2 and ischemic cardiomyopathy: Moreover, in a larger biopsy cohort, it was shown that Tet2 expression was more abundantly expressed in cardiotoxicity biopsies vs. control biopsies, but also compared with non-cardiotoxic non-ischemic cardiomyopathy patients (Figure 4).